ライフサイエンスコーパス: gingival crevicular fluid

1 esent at up to 70% of serum concentration in gingival crevicular fluid.

2 um health and measured MMP-9 levels in their gingival crevicular fluid, a liquid that seeps out from

3 tching could enhance DOX availability in the gingival crevicular fluid after its release from the col

4 ival biofilm as well as on biomarkers in the gingival crevicular fluid after SRP.

5 variety of host markers in serum/plasma and gingival crevicular fluid along with clinical parameter

6 linical trails to reduce MMP activity in the gingival crevicular fluid and gingival tissues, with a r

7 ssive periodontitis have type-1 cytokines in gingival crevicular fluid and high titers of IFN-gamma-d

8 ependent IgG2 reactive with P. gingivalis in gingival crevicular fluid and serum.

9 egulated and is detected at higher levels in gingival crevicular fluid and tissue specimens.

10 Recipient (gingival crevicular fluid) and donor (wound fluid) site

11 antiviral and inflammatory cytokines in the gingival crevicular fluid, and a synergistic effect was

12 peptides are secreted--specifically saliva, gingival crevicular fluid, and airway surface fluid--dif

13 tissues, effect on alveolar bone, effect on gingival crevicular fluid, and effect on salivary flow.

14 study, we examined whether IgG in serum and gingival crevicular fluid, and IgG locally produced by p

15 Saliva, salivary glands, gingival crevicular fluid, and supragingival biofilms ma

16 Bioassay of doxycycline in gingival crevicular fluid associated with presence of AB

17 unstimulated whole-mouth salivary flow rate, gingival crevicular fluid biomarkers).

18 Gingival crevicular fluid, bleeding on probing (BOP), an

19 L), and bleeding on probing (BOP) as well as gingival crevicular fluid bone marker assessment (ICTP)

20 nvestigate if levels of IL-1alpha protein in gingival crevicular fluid can be correlated to patient g

21 tudy, we performed a metabolomic analysis of gingival crevicular fluid collected from healthy, gingiv

22 The analysis of gingival crevicular fluid components offers great potent

23 of periodontal pockets, which are bathed in gingival crevicular fluid consisting of 70% of blood pla

24 igh levels of gingipain activity detected in gingival crevicular fluid could implicate a role for gin

25 rs could be used for measuring ions from the gingival crevicular fluid directly into the peri-odontal

26 Antibiotics at concentrations detectable in gingival crevicular fluid do not dramatically reduce tot

27 At control sites, a significant decrease in gingival crevicular fluid flow rate was evident at the c

28 evels of galactose-deficient IgG in sera and gingival crevicular fluid from periodontal disease patie

29 combinant segments of FN and used to analyze gingival crevicular fluid from periodontal disease sites

30 matrix metalloproteinase-9 (MMP-9) levels in gingival crevicular fluid (GCF) across various periodont

31 their association with plaque index (PI) and gingival crevicular fluid (GCF) after OHR for 1 week.

32 ver, little is known about MMP reductions in gingival crevicular fluid (GCF) after therapy.

33 pth (PD) and local inflammatory mediators in gingival crevicular fluid (GCF) among patients with untr

34 microbial testing, histological examination, gingival crevicular fluid (GCF) analysis for the levels

35 d with that in chronic periodontitis (CP) by gingival crevicular fluid (GCF) analysis of myeloperoxid

36 vels in peri-implant crevicular fluid (PICF)/gingival crevicular fluid (GCF) and a selection of subgi

37 At each visit, gingival crevicular fluid (GCF) and blood were collected

38 whether specific FN fragments are present in gingival crevicular fluid (GCF) and can be used as marke

39 s study were to delineate cyto/chemokines in gingival crevicular fluid (GCF) and evaluate systemic le

40 een the levels of stress-related hormones in gingival crevicular fluid (GCF) and extent/severity of p

41 PAF levels were investigated in gingival crevicular fluid (GCF) and gingival tissue (GT)

42 LTB4 levels were investigated in gingival crevicular fluid (GCF) and gingival tissue (GT)

43 The gingival crevicular fluid (GCF) and monocytic secretion

44 onal flap surgery on growth factor levels in gingival crevicular fluid (GCF) and periodontal healing.

45 parameters, and levels of cyto/chemokines in gingival crevicular fluid (GCF) and peripheral blood res

46 e aim of the present study is to investigate gingival crevicular fluid (GCF) and plasma acute-phase c

47 im of this study is to investigate levels of gingival crevicular fluid (GCF) and plasma TGM-2 and oxi

48 n detached subgingival bacteria collected in gingival crevicular fluid (GCF) and RA parameters.

49 This study aimed to investigate the gingival crevicular fluid (GCF) and salivary HIF-1alpha,

50 ects of initial periodontal treatment on the gingival crevicular fluid (GCF) and salivary levels of 8

51 rapy during pregnancy on periodontal health, gingival crevicular fluid (GCF) and serum cytokines, and

52 This study aimed to investigate gingival crevicular fluid (GCF) and serum levels of LRG,

53 This study aimed to investigate gingival crevicular fluid (GCF) and serum levels of LRG,

54 This study is performed to evaluate gingival crevicular fluid (GCF) and serum levels of solu

55 udy is to evaluate YKL-40 and IL-6 levels in gingival crevicular fluid (GCF) and serum of patients wi

56 To evaluate the cytokine profile in gingival crevicular fluid (GCF) and serum of pediatric i

57 ory and anti-inflammatory cytokine levels in gingival crevicular fluid (GCF) and serum of rheumatoid

58 f non-surgical periodontal therapy (NSPT) on gingival crevicular fluid (GCF) and serum progranulin (P

59 6, and tumor necrosis factor (TNF)-alpha, in gingival crevicular fluid (GCF) and serum samples betwee

60 ), and oxidative stress index (OSI) in their gingival crevicular fluid (GCF) and serum were recorded.

61 At baseline, gingival crevicular fluid (GCF) and subgingival plaque w

62 Gingival crevicular fluid (GCF) and subgingival plaque w

63 sforming growth factor-beta 1 (TGF-beta1) in gingival crevicular fluid (GCF) and the periodontal stat

64 ociated with apoptosis in serum, saliva, and gingival crevicular fluid (GCF) and their association wi

65 riodontitis-specific molecular signatures in gingival crevicular fluid (GCF) and to confirm clinical

66 luate the antibody responses in non-invasive gingival crevicular fluid (GCF) and unstimulated whole s

67 PG) levels and RANKL/OPG ratios in serum and gingival crevicular fluid (GCF) are investigated in pati

68 Volumetric alterations in gingival crevicular fluid (GCF) are widely accepted to b

69 in peri-implant crevicular fluid (PICF) and gingival crevicular fluid (GCF) as surrogate measures of

70 of this study is to determine whether either gingival crevicular fluid (GCF) bacterial gingivain/ging

71 ives of this study were to measure levels of gingival crevicular fluid (GCF) biomarkers and subgingiv

72 Gingival crevicular fluid (GCF) biomarkers associated wi

73 easured in serum, synovial fluid, saliva and gingival crevicular fluid (GCF) by multiplex immunoassay

74 e present study are to: 1) determine whether gingival crevicular fluid (GCF) chemerin is a novel pred

75 rformed an unbiased metabolomic profiling of gingival crevicular fluid (GCF) collected from healthy,

76 omitans (Aa), Tannerella forsythia (Tf), and gingival crevicular fluid (GCF) concentration of interle

77 orted to present with increased salivary and gingival crevicular fluid (GCF) concentrations of cytoki

78 e aim of this study was to compare serum and gingival crevicular fluid (GCF) concentrations of sICAM-

79 amed tissue, suggesting that their levels in gingival crevicular fluid (GCF) could be increased at gi

80 Subgingival plaque microbial profiles and gingival crevicular fluid (GCF) cytokine levels were det

81 It may be hypothesized that the gingival crevicular fluid (GCF) cytokine profile in pati

82 n-surgical periodontal therapy (NSPT) on the gingival crevicular fluid (GCF) cytokine profile in site

83 atelet derived growth factor-BB (PDGF-BB) in gingival crevicular fluid (GCF) during early healing per

84 f matrix metalloproteinase (MMP)-8 and -9 in gingival crevicular fluid (GCF) during early pregnancy w

85 Aims of the study are to determine serum and gingival crevicular fluid (GCF) endocan levels in the pa

86 hil counts, systemic priming of neutrophils, gingival crevicular fluid (GCF) expression of inflammato

87 Gingival crevicular fluid (GCF) flow was significantly l

88 luid (PICF) samples from the new implant and gingival crevicular fluid (GCF) from adjacent teeth were

89 the presence of Th1-associated cytokines in gingival crevicular fluid (GCF) from LagP patients and t

90 platelet-derived growth factor (PDGF-BB) in gingival crevicular fluid (GCF) from localized intrabony

91 resence of human herpesviruses in saliva and gingival crevicular fluid (GCF) from patients with CKD.

92 ect of non-surgical periodontal treatment on gingival crevicular fluid (GCF) HIF-1alpha, VEGF, and TN

93 m human gingival fibroblasts in vitro and in gingival crevicular fluid (GCF) in a randomized controll

94 te and compare the levels of resistin in the gingival crevicular fluid (GCF) in health, chronic perio

95 r aim was to determine levels of ADAMTS-1 in gingival crevicular fluid (GCF) in patients with advance

96 rleukin (IL)-11 and IL-17 and their ratio in gingival crevicular fluid (GCF) in patients with AgP.

97 2) and matrix metalloproteinase-8 (MMP-8) in gingival crevicular fluid (GCF) in patients with periodo

98 he clinical parameters of disease and on the gingival crevicular fluid (GCF) inflammatory mediator in

99 s, levels of eight oral pathogens, levels of gingival crevicular fluid (GCF) interleukin-1beta (IL-1b

100 outh) on clinical periodontal parameters and gingival crevicular fluid (GCF) levels of 15-epi-lipoxin

101 bulin G (IgG) titers to 17 bacteria, and the gingival crevicular fluid (GCF) levels of 16 inflammator

102 The current study determines gingival crevicular fluid (GCF) levels of fibrosis-relat

103 Comparing the gingival crevicular fluid (GCF) levels of galectin-3, pe

104 Comparing the gingival crevicular fluid (GCF) levels of galectin-3, pe

105 he purpose of this study was to test whether gingival crevicular fluid (GCF) levels of IL-1beta and t

106 Gingival crevicular fluid (GCF) levels of interleukin (I

107 ne the biochemical profile by evaluating the gingival crevicular fluid (GCF) levels of interleukin (I

108 ssessing clinical periodontal parameters and gingival crevicular fluid (GCF) levels of interleukin (I

109 Serum, saliva, and gingival crevicular fluid (GCF) levels of interleukin (I

110 mine whether glycemic control was related to gingival crevicular fluid (GCF) levels of interleukin-1b

111 study is to determine the serum, saliva and gingival crevicular fluid (GCF) levels of MT in smokers

112 f non-surgical periodontal therapy (NSPT) on gingival crevicular fluid (GCF) levels of semaphorin-4D

113 en the outcome of a chairside test measuring gingival crevicular fluid (GCF) levels of the enzyme asp

114 Gingival crevicular fluid (GCF) levels of the polymorpho

115 Four different gingival crevicular fluid (GCF) markers from 14 patients

116 Different gingival crevicular fluid (GCF) matrix metalloproteinase

117 he aim of this study is to explore different gingival crevicular fluid (GCF) matrix metalloproteinase

118 on clinical and microbiologic parameters and gingival crevicular fluid (GCF) matrix metalloproteinase

119 ncreased levels of immunoglobulin A (IgA) in gingival crevicular fluid (GCF) may be "protective", whi

120 The analysis of biomarkers in gingival crevicular fluid (GCF) may be helpful in foreca

121 e presence of inflammatory products found in gingival crevicular fluid (GCF) may be of value in evalu

122 Biochemical markers harvested from gingival crevicular fluid (GCF) may be useful to identif

123 Estimation of serum and gingival crevicular fluid (GCF) MCP levels could be a re

124 of this study is to investigate salivary and gingival crevicular fluid (GCF) nitric oxide (NO) metabo

125 ted at baseline and 2 weeks postoperatively, gingival crevicular fluid (GCF) obtained at baseline, 2

126 pare them with their corresponding levels in gingival crevicular fluid (GCF) obtained from the same p

127 ined by enzyme-linked immunosorbent assay in gingival crevicular fluid (GCF) of 24 individuals with p

128 of caspase-8, -9, and AIF were evaluated in gingival crevicular fluid (GCF) of all participants via

129 cation end products (AGEs) are higher in the gingival crevicular fluid (GCF) of chronic periodontitis

130 study is to determine visfatin levels in the gingival crevicular fluid (GCF) of healthy individuals a

131 or necrosis factor-alpha (TNF-alpha), in the gingival crevicular fluid (GCF) of individuals with peri

132 aims to investigate the levels of sTREM-1 in gingival crevicular fluid (GCF) of individuals without p

133 ctoferrin, 2 microbiostatic proteins, in the gingival crevicular fluid (GCF) of normal children.

134 s have previously demonstrated that IgG from gingival crevicular fluid (GCF) of patients with chronic

135 peptides 1 through 3 (HNP 1-3) levels in the gingival crevicular fluid (GCF) of patients with periodo

136 rrent study was to evaluate MFN1 and MFN2 in gingival crevicular fluid (GCF) of patients with periodo

137 ming growth factor beta 1 (TGF-beta1) in the gingival crevicular fluid (GCF) of patients with periodo

138 nuclear factor-kappaB ligand (RANKL) in the gingival crevicular fluid (GCF) of patients with periodo

139 hesized that ADAM8 levels are also raised in gingival crevicular fluid (GCF) of patients with periodo

140 ypothesis that TACE would be elevated in the gingival crevicular fluid (GCF) of persons with periodon

141 lagen degradation and bone resorption in the gingival crevicular fluid (GCF) of the same vulnerable s

142 This study aims to assess gingival crevicular fluid (GCF) PLAP-1, sclerostin, and

143 nalysis of alveolar bone, and measurement of gingival crevicular fluid (GCF) prostaglandin E2 (PGE2)

144 ketorolac tromethamine mouthrinse (0.1%) on gingival crevicular fluid (GCF) prostaglandin E2 (PGE2)

145 proteome and the differential expression of gingival crevicular fluid (GCF) proteins using sequentia

146 rall proteome and differential expression of gingival crevicular fluid (GCF) proteins using the seque

147 DL-arginine naphthylamine [BANA] assay), and gingival crevicular fluid (GCF) pyridinoline cross-linke

148 Gingival crevicular fluid (GCF) samples and clinical par

149 and IL-10 levels were assessed in serum and gingival crevicular fluid (GCF) samples at baseline and

150 on the following: 1) biochemical content in gingival crevicular fluid (GCF) samples from sites of gi

151 ical measurements (PD, CAL, PI, BOP, GI) and gingival crevicular fluid (GCF) samples were collected a

152 Clinical periodontal parameters and gingival crevicular fluid (GCF) samples were collected a

153 Serum, saliva, and gingival crevicular fluid (GCF) samples were collected t

154 fter assessment of periodontal measurements, gingival crevicular fluid (GCF) samples were taken at on

155 cation of multiple inflammatory mediators in gingival crevicular fluid (GCF) samples.

156 erase chain reaction was performed using the gingival crevicular fluid (GCF) samples.

157 ocally delivered antibiotics on the level of gingival crevicular fluid (GCF) stromelysin (SL) and tis

158 The hypothesis to be tested was that gingival crevicular fluid (GCF) TGF-beta1 production was

159 zithromycin are higher and more sustained in gingival crevicular fluid (GCF) than in serum.

160 d tetracyclines reach steady-state levels in gingival crevicular fluid (GCF) that are several-fold hi

161 Biofilm and gingival crevicular fluid (GCF) to assess the microbiome

162 Secondary purposes were to compare gingival crevicular fluid (GCF) volume and GCF concentra

163 plaque index (PI), gingival index (GI), and gingival crevicular fluid (GCF) volume from days 0 to 21

164 l index (GI), bleeding on probing (BOP), PD, gingival crevicular fluid (GCF) volume, and total amount

165 Gingival crevicular fluid (GCF) was also collected to me

166 Gingival crevicular fluid (GCF) was analyzed for the sam

167 cig use on biological profiles in saliva and gingival crevicular fluid (GCF) was assessed and compare

168 Clinical evaluation was performed, and gingival crevicular fluid (GCF) was collected for select

169 bleeding on probing (BOP) were measured, and gingival crevicular fluid (GCF) was collected from five

170 Gingival crevicular fluid (GCF) was collected in a cohor

171 The mean concentration of 0.5% CLM in gingival crevicular fluid (GCF) was estimated by reverse

172 Gingival crevicular fluid (GCF) was obtained from 2 huma

173 The volume of gingival crevicular fluid (GCF) was quantified, and inte

174 Gingival crevicular fluid (GCF) was sampled for the anal

175 m, peri-implant crevicular fluid (PICF), and gingival crevicular fluid (GCF) were collected from pati

176 e-induced proinflammatory cytokines level in gingival crevicular fluid (GCF) were evaluated.

177 Levels of visfatin in serum and gingival crevicular fluid (GCF) were explored in patient

178 h factor-B (TGF-B) and collagen-1 (Col-1) in gingival crevicular fluid (GCF) were measured using enzy

179 Samples of gingival crevicular fluid (GCF) were obtained 1, 3, 7, 1

180 clinical status and the enzymatic profile of gingival crevicular fluid (GCF) when given as adjunct to

181 Beta-glucuronidase (betaG) in gingival crevicular fluid (GCF), a marker of neutrophil

182 Saliva, gingival crevicular fluid (GCF), and blood samples from

183 from necrotic cells, has been identified in gingival crevicular fluid (GCF), and elevated levels are

184 he expression patterns of ghrelin in saliva, gingival crevicular fluid (GCF), and gingival tissue, as

185 ts of subgingival temperature, flow rates of gingival crevicular fluid (GCF), and neutrophil emigrati

186 This study investigates whether gingival crevicular fluid (GCF), saliva, and plasma leve

187 The aim of this study is to evaluate gingival crevicular fluid (GCF), saliva, and plasma leve

188 MMP-9, and TIMP-1 levels were determined in gingival crevicular fluid (GCF), saliva, and serum by im

189 The aim of this study is to evaluate the gingival crevicular fluid (GCF), saliva, and serum conce

190 Gingival crevicular fluid (GCF), saliva, and serum level

191 Pharmacokinetic data were obtained from gingival crevicular fluid (GCF), saliva, and serum of ad

192 -17F, IL-17A/F, and IL-17E (IL-25) levels in gingival crevicular fluid (GCF), saliva, and serum of no

193 Gingival crevicular fluid (GCF), serum, and saliva sampl

194 l blood, as well as gingival tissue (GT) and gingival crevicular fluid (GCF), was obtained from a tot

195 ming growth factor beta 1 (TGF-beta1) in the gingival crevicular fluid (GCF), which accumulates aroun

196 s with data on microbial plaque composition, gingival crevicular fluid (GCF)-interleukin (IL)-1beta l

197 ganic substrates are different in saliva vs. gingival crevicular fluid (GCF).

198 t local anti-PC and anti-oxLDL production in gingival crevicular fluid (GCF).

199 mmune responses and tissue remodeling in the gingival crevicular fluid (GCF).

200 ential amino acid, enters the oral cavity in gingival crevicular fluid (GCF).

201 mor necrosis factor-alpha (TNF-alpha) in the gingival crevicular fluid (GCF).

202 esent study are to comparatively analyze the gingival crevicular fluid (GCF)/peri-implant sulcus flui

203 , 6, and 9 days) were compared with adjacent gingival crevicular fluid (GCF; at baseline, 1, and 4 mo

204 were found between DHA and control for both gingival crevicular fluid hsCRP (-5.3 ng/mL, standard er

205 pathogens) and local inflammatory response (gingival crevicular fluid IL-1beta) and derive periodont

206 iseases from real samples, such as saliva or gingival crevicular fluid in a short time as a point-of-

207 o evaluate the levels of these biomarkers in gingival crevicular fluid in periodontal health, gingivi

208 ontal clinical parameters were recorded, and gingival crevicular fluid levels of biomarkers were anal

209 pocket depth, clinical attachment level, and gingival crevicular fluid levels of matrix metalloprotei

210 n and bone loss, which correlated with lower gingival crevicular fluid levels of proinflammatory medi

211 ts in response to a major human salivary and gingival crevicular fluid LPA species, 18:1, and that th

212 n clinical parameters and cytokine levels in gingival crevicular fluid of dogs with experimental peri

213 clinical parameters and cytokine profiles in gingival crevicular fluid of patients with moderate-to-s

214 ipocytokines were evaluated in the serum and gingival crevicular fluid of shallow and deep sites by e

215 s, pocket depths, gingival inflammation, and gingival crevicular fluid RANKL and MMP-8 levels (p < 0.

216 was evaluated clinically and biochemically (gingival crevicular fluid RANKL, OPG, MMP-8, and serum I

217 Total RNA was extracted from gingival crevicular fluid samples and relative gene expr

218 y, we detected the karilysin gene in >90% of gingival crevicular fluid samples containing T. forsythi

219 Detection of these gene products in gingival crevicular fluid samples from human disease may

220 Gingival crevicular fluid samples from six healthy, six

221 Diagnostic efficacy was evaluated in gingival crevicular fluid samples from subjects with and

222 Gingival crevicular fluid samples were analyzed for chan

223 Marginal and subgingival plaque and gingival crevicular fluid samples were collected at base

224 Marginal and subgingival plaque and gingival crevicular fluid samples were collected from 15

225 Gingival crevicular fluid samples were used to monitor d

226 Saliva, gingival crevicular fluid, subgingival plaque, and blood

227 es have significantly higher IL-1beta in the gingival crevicular fluid than females during health and

228 bleeding on probing [BOP]) and a sampling of gingival crevicular fluid, the composite restoration was

229 plaque index (PlI), gingival index (GI), and gingival crevicular fluid volume (GCF) were evaluated fo

230 4) relative attachment levels (RAL); and 5) gingival crevicular fluid volume (GCF).

231 In addition, gingival crevicular fluid was analyzed for an inflammati

232 Gingival crevicular fluid was collected before treatment

233 The mean concentration of MF in gingival crevicular fluid was estimated by reverse-phase

234 Samples of subgingival biofilm and gingival crevicular fluid were collected at baseline and

235 Plaque and gingival crevicular fluid were collected for trypsin-lik

236 ngivalis-specific immunoglobulin G levels in gingival crevicular fluid were measured in primates immu

237 Samples of gingival crevicular fluid were obtained 1, 3, 7, 14, and